Zn-Complexed Brain Protein Hydrolysate Bioavailability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current mammalian brain protein hydrolysate products, while effective in treating neurological conditions, lack extension into nutritional supplements and have limited neural system effects, particularly on cerebral endothelial integrity and age-associated memory impairment.

Innovation Solution

A method involving the production of a mammalian brain protein hydrolysate composition by adding Zn ions, preferably as zinc gluconate, to form a complex with the hydrolysate, optimizing pH and concentration for enhanced bioavailability and effectiveness as a nutritional supplement.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If Zn ions are added to form a complex with brain protein hydrolysate, then bioavailability and neural system effects are improved, but product complexity and manufacturing steps increase

Engineering Contradiction:
ImprovebioavailabilityVSAvoidproduct complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent creates a composite material by forming a complex between Zn ions and brain protein hydrolysate. This composite structure enhances the bioavailability and neural system effects of the hydrolysate while maintaining it as a single integrated product entity, resolving the contradiction between improved reliability and increased complexity.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent optimizes specific parameters including Zn ion concentration (0.1-10 mM), pH range (5.0-7.5), and temperature (20-37°C) to maximize complex formation efficiency. By controlling these parameters, the patent achieves high bioavailability while keeping the manufacturing process manageable and not excessively complex.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If Zn ions are added to form a complex with brain protein hydrolysate, then endothelial permeability and anti-inflammatory effects are enhanced, but manufacturing precision and process control requirements increase

Engineering Contradiction:
Improveneural system effectsVSAvoidprocess control
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent specifies optimal parameter ranges for complex formation: Zn ion concentration of 0.1-10 mM, pH of 5.0-7.5, and temperature of 20-37°C. These well-defined parameter ranges enable consistent manufacturing with controlled precision while achieving enhanced neural system effects, resolving the contradiction between reliability and manufacturing precision requirements.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If the patent extends brain protein hydrolysate application to nutritional supplements, then product versatility and market applicability increase, but regulatory requirements and safety standards become more stringent

Engineering Contradiction:
Improveproduct versatilityVSAvoidsafety standards
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent develops a multi-functional product that serves both pharmaceutical and nutritional supplement applications. The Zn-complexed brain protein hydrolysate can be used for treating neurological conditions while also functioning as a cognitive health supplement, thereby increasing product versatility. The standardized manufacturing process and defined composition help meet varying regulatory requirements across different application domains.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The Zn-complexed mammalian brain protein hydrolysate exhibits improved neural system effects, including enhanced endothelial permeability and reduced pro-inflammatory proteins, offering potential for both therapeutic and preventive applications in neurological conditions and age-related cognitive decline.

Implementation Method 1

adding Zn ions to the mammalian brain protein hydrolysate to form a complex comprising the Zn ions and the protein hydrolysate

Methodology Applied
Scientific EffectComplex formation: Chemical Bonding

Data Source

PatentUS20230302080A1Method for producing a mammalian brain protein hydrolysate
Publication Date: 2023.09.28 EVER NEURO PHARMA GMBH
  • US20230302080A1 patent drawing
  • US20230302080A1 patent drawing
  • US20230302080A1 patent drawing

AI summary

A method for producing a mammalian brain protein hydrolysate composition, by providing a mammalian brain protein hydrolysate, adding Zn ions to the mammalian brain protein hydrolysate to form a complex with the Zn ions and the mammalian brain protein hydrolysate, and obtaining the complex with the Zn ions and the mammalian brain protein hydrolysate in a mammalian brain protein hydrolysate composition. A composition with a mammalian brain protein hydrolysate. A nutritional supplement with a mammalian brain protein hydrolysate. A pharmaceutical composition with a mammalian brain protein hydrolysate.